MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    Hot cross bun sign in progressive ataxia with ELVOL4 mutation

    M. Moreno-Escobar, R. Tripathi (Morgantown, USA)

    Objective: To describe a case of progressive gait abnormalities and bulbar dysfunction which was associated with genetic mutation and neuroimaging findings representative of spinocerebellar ataxia…
  • MDS Virtual Congress 2021

    Hemichorea and contralateral hemidystonia after acute stroke

    P. Lorenzo Barreto, R. Sainz Amo, F. Pérez Trapote, A. Sáez Marín, E. Stiauren Fernández, JC. Martínez Castrillo, S. García Madrona (Madrid, Spain)

    Objective: To describe an unusual presentation of poststroke movement disorders. Background: Movement disorders occur uncommonly in association with stroke (1%), despite the frequent involvement of…
  • MDS Virtual Congress 2021

    A phase IV, randomized, double-blind cross-over study comparing the clinical safety, efficacy and duration of abobotulinumtoxinA with onabotulinumtoxinA in adults with upper-limb spasticity: The DIRECTION study

    A. Esquenazi, Z. Ayyoub, M. Verduzco-Gutierrez, P. Maisonobe, J. Otto, A. Patel (Elkins Park, USA)

    Objective: To evaluate the safety and efficacy of abobotulinumtoxinA in comparison to onabotulinumtoxinA when used at optimized doses in approved muscles common to both products’…
  • MDS Virtual Congress 2021

    Benefits of Treatment with OnabotulinumtoxinA in Naive and Non-naive Patients with Cervical Dystonia are Sustained over Time: Preliminary Completer Analysis from CD PROBE

    P. Agarwal, M. Schwartz, A. Zuzek, A. Patel (Kirkland, USA)

    Objective: This analysis evaluated the sustained effects of onabotulinumtoxinA in patients with CD who were naive or non-naive to botulinum toxin at enrollment in CD…
  • MDS Virtual Congress 2021

    Pain in cervical dystonia: A meta-analysis of outcomes following treatment with abobotulinumtoxinA in randomized, controlled clinical studies

    R. Rosales, L. Cuffe, B. Regnault, R. Trosch (Manila, Philippines)

    Objective: The aim of this meta-analysis of pivotal studies was to evaluate the efficacy of abobotulinumtoxinA (AboBoNT-A) in reducing pain in patients with cervical dystonia…
  • MDS Virtual Congress 2021

    A case of YY1-related isolated dystonia with severe oromandibular involvement

    MJ. Malaquias, R. Rodrigues, J. Damásio, A. Mendes, J. Freixo, M. Magalhães (Porto, Portugal)

    Objective: 0 Background: Introduction: YY1 disease-causing variants are responsible for Grabiele-de-Vries syndrome, an autosomal dominant condition characterized by psychomotor developmental (PD) delay, cognitive impairment, facial dysmorphism…
  • MDS Virtual Congress 2021

    Exploring Local Field Potential changes in Dystonic Camptocormia.

    M. Chua, C. Harrington, S. Stanslaski, M. Hayes, G. Cosgrove, T. Herrington (Boston, USA)

    Objective: To describe a novel technology for detection of local field potentials in bilateral GPi-DBS to identify local field potential biomarker changes in dystonic camptocormia.…
  • MDS Virtual Congress 2021

    Outcomes of a Peer Reviewing Education and Mentoring Program

    D. Garbin Diluca, A. Kirby, C. Goetz (Toronto, Canada)

    Objective: To describe the outcomes of the first year of an educational program in peer reviewing instituted by the Young Members Group of the International…
  • MDS Virtual Congress 2021

    Clinical epidemiology of movement disorders in Douala General Hospital, Cameroon: A two years retrospective study

    D. Gams Massi, AM. Magnerou, G. Tchumno Mayoue, EA. Babe, NY. Mapoure (Douala, Cameroon)

    Objective: The aim of this study was to determine the frequency of movement disorders and their characteristics in the outpatient department of neurology at the…
  • MDS Virtual Congress 2021

    Prevalence of advanced Parkinson’s disease in Thai patients with Parkinson’s disease using The Consensus on the Definition of Advance Parkinson’s disease (CEPA Study): A single-center study

    K. Thanapermpool, J. Srikajon, Y. Pitakpatapee, W. Saengphatrachai, T. Sangpeamsook, T. Wangthumrong, A. Pisarnpong, P. Srivanitchapoom (Bangkok, Thailand)

    Objective: This study's primary aim was to identify the prevalence of APD in Thai PD patients using CEPA’s definition. Demographic data, some motor and non-motor symptoms…
  • « Previous Page
  • 1
  • …
  • 73
  • 74
  • 75
  • 76
  • 77
  • …
  • 132
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley